SCHEDULE: Qian Zhuang, 11.2 Capital Report 9.8% Stake in Hinge Health
Beneficial Ownership Report
Qian Zhuang and affiliated 11.2 Capital entities disclosed beneficial ownership of 9.8% of Hinge Health, Inc.'s Class A Common Stock as of December 31, 2025.
Summary
- Qian Zhuang, through affiliated entities, beneficially owns 3,704,524 shares of Hinge Health, Inc.'s Class A Common Stock.
- This represents 9.8% of the outstanding Class A Common Stock.
- The shares are held by 11.2 Capital I, L.P. (2,703,954 shares), 11.2 Capital HH, LLC (171,550 shares), and 11.2 Capital IVY, LLC (829,020 shares).
- Qian Zhuang is the sole managing member of the general partner of 11.2 Capital I, L.P. and the manager of 11.2 Capital HH, LLC and 11.2 Capital IVY, LLC, granting sole voting and dispositive power over these shares.
- The calculation is based on 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025.
- The Reporting Persons expressly disclaim status as a 'group' for purposes of this Schedule 13G.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive indicator of investor confidence in Hinge Health, Inc., given the substantial beneficial ownership reported by Qian Zhuang and affiliated entities.
Positives
- Significant beneficial ownership by Qian Zhuang and affiliated 11.2 Capital entities, totaling 9.8% of Class A Common Stock, indicates strong investor confidence in Hinge Health, Inc.
- The disclosure is a routine regulatory filing for a substantial passive investment, suggesting stability in the ownership structure.
Negatives
- No explicit negatives are present in this beneficial ownership disclosure.
Risks
- No specific risks are mentioned in this Schedule 13G filing.
Future Outlook
This Schedule 13G filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is a disclosure of beneficial ownership.
Industry Context
StockSavvy.ai notes that significant beneficial ownership by venture capital firms or individuals like Qian Zhuang often indicates long-term strategic interest in growth-oriented companies within the digital health or healthcare technology sector, where Hinge Health operates. Such disclosures provide transparency into major shareholder positions, which can influence market perception of a company's stability and potential.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, which can influence market sentiment and potentially signal confidence from large investors.
- Management: Awareness of substantial shareholder positions can influence strategic decisions and corporate governance considerations.
Next Steps
- No specific future actions, events, or milestones are mentioned in this filing.
Key Dates
| Date | Description |
|---|---|
| 2025-08-14 | Date of original Joint Filing Agreement referenced in Exhibit 99.1. |
| 2025-10-30 | Date as of which 37,919,155 shares of Class A Common Stock were outstanding, used for percentage calculations. |
| 2025-11-07 | Date Hinge Health, Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2025-12-31 | Date of the event which required the filing of this Schedule 13G Amendment No. 1, reflecting the beneficial ownership. |
| 2026-02-13 | Date the Schedule 13G Amendment No. 1 was signed by the Reporting Persons. |
Recommendation
holdThe filing indicates a substantial beneficial ownership stake by Qian Zhuang and affiliated entities, suggesting continued investor confidence. While not a performance report, this level of ownership by a sophisticated investor typically warrants a 'hold' recommendation for existing shareholders and further due diligence for potential investors.
Keywords
Hinge Health, 11.2 Capital, Qian Zhuang, beneficial ownership, Schedule 13G, Class A Common Stock, institutional investor, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.